CS
CLOV icon

Credit Suisse’s Clover Health Investments CLOV Stock Holding History

Credit Suisse’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$323K Buy
407,395
+33,156
+9% +$30.2K ﹤0.01% 2800
2023
Q4 		$356K Buy
374,239
+51,403
+16% +$50.5K ﹤0.01% 2873
2023
Q3 		$349K Sell
322,836
-18,891
-6% -$22.5K ﹤0.01% 2873
2023
Q2 		$307K Buy
341,727
+82,710
+32% +$73.4K ﹤0.01% 2998
2023
Q1 		$219K Buy
259,017
+82
+0% +$90 ﹤0.01% 3086
2022
Q4 		$241K Sell
258,935
-24,064
-9% -$32.1K ﹤0.01% 3120
2022
Q3 		$481K Buy
282,999
+70,507
+33% +$185K ﹤0.01% 2809
2022
Q2 		$455K Buy
212,492
+13,295
+7% +$35.3K ﹤0.01% 2905
2022
Q1 		$707K Buy
199,197
+12,630
+7% +$36.6K ﹤0.01% 2773
2021
Q4 		$695K Buy
186,567
+98,922
+113% +$607K ﹤0.01% 3592
2021
Q3 		$647K Buy
87,645
+280
+0.3% +$2.4K ﹤0.01% 3641
2021
Q2 		$1.16M Buy
+87,365
New +$858K ﹤0.01% 3271
2020
Q4 		– Sell
-25,000
Closed -$312K – 4345
2020
Q3 		$312K Sell
25,000
-25,000
-50% -$277K ﹤0.01% 3631
2020
Q2 		$559K Buy
+50,000
New +$538K ﹤0.01% 3253

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse's CLOV Position: Q1 2024 in Review

Credit Suisse increased its Clover Health Investments (CLOV) stake by 8.9% in Q1 2024, buying an estimated $30.2K and bringing the position to 407,395 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #2800.

Credit Suisse first reported a position in CLOV in Q2 2020 and has held it in 14 quarters since. The position peaked at $1.16M in Q2 2021. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

  • Credit Suisse held 407,395 shares of Clover Health Investments worth $323K as of Q1 2024.
  • Credit Suisse bought 33,156 Clover Health Investments shares in Q1 2024, an estimated $30.2K.
  • Clover Health Investments made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2800 holding.
  • Credit Suisse first reported a position in Clover Health Investments in Q2 2020 and has held it in 14 quarters since.
  • Credit Suisse's Clover Health Investments position peaked at $1.16M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.